CLINDAMYCIN HYDROCHLORIDE by Teva is clinical pharmacology human pharmacology absorption pharmacokinetic studies with a 150 mg oral dose of clindamycin hydrochloride in 24 normal adult volunteers showed that clindamycin was rapidly absorbed after oral administration. Approved for the treatment of serious infections caused by susceptible anaerobic bacteria, the treatment of serious infections due to susceptible strains of streptococci, pneumococci and 1 more indications. First approved in 1989.
Drug data last refreshed 19h ago
CLINICAL PHARMACOLOGY Human Pharmacology Absorption Pharmacokinetic studies with a 150 mg oral dose of clindamycin hydrochloride in 24 normal adult volunteers showed that clindamycin was rapidly absorbed after oral administration. An average peak serum concentration of 2.50 mcg/mL was reached in 45…
Worked on CLINDAMYCIN HYDROCHLORIDE at Teva? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Compound Adapalene and Clindamycin Hydrochloride Gel in Treatment of Patients With Acne